Frequency of Gastroesophageal Reflux in Diabetic Patients without Gastrointestinal Symptoms
Article Sidebar
Main Article Content
Abstract
Objective: Diabetes Mellitus (DM) represents a complex metabolic disorder characterized by chronic hyperglycemia resulting from insulin dysfunction. Numerous studies have underscored the prevalence of gastrointestinal complications in individuals with DM. gastrointestinal complications in DM patients primarily stem from changes in gastrointestinal motility patterns. This study aimed to investigate the prevalence of asymptomatic Gastroesophageal Reflux Disease (GERD) in patients with DM due to the frequent occurrence of gastrointestinal (GI) complications in DM patients, which are often underdiagnosed owing to their asymptomatic nature. We further aimed to elucidate the potential correlations between GERD and peripheral neuropathy in DM patients.
Materials and Methods: Within this prospective study, 20 patients diagnosed with DM and without symptoms of GERD were selected from the Internal Medicine and Gastroenterology outpatient clinics. Patients were diagnosed with the primary method of GERD detection 24-hour ambulatory pH monitoring. Patients, devoid of any GERD symptoms and dyspepsia, were assessed through a dyspepsia questionnaire, followed by determining fasting glucose levels, HbA1c values, and Body Mass Index (BMI) calculations. Subsequent evaluations involved esophageal manometry and 24-hour ambulatory.
Results: The evaluation of results using 24-hour ambulatory pH meter testing revealed a 40% prevalence of GERD in asymptomatic DM patients (8 out of 20 patients). A comparative analysis between DM patients with and without GERD, based on age, sex, BMI, HbA1c values, and fasting blood glucose levels, demonstrated no statistically significant differences. However, the frequency of GERD was significantly elevated in asymptomatic DM patients compared to the general population in our country (p<0.05).
Conclusion: The findings indicate that 40% of DM patients exhibit GERD even in the absence of symptoms, highlighting the ubiquity of GI symptoms and complications in DM patients. This underscores the critical need for enhanced vigilance and proactive measures for GERD complications in this demographic. Implementing precise dietary plans, lifestyle modifications, and appropriate pharmacologic interventions can substantially ameliorate the quality of life and thwart GERD-related complications, even in DM patients not manifesting overt GERD symptoms.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Accepted 2024-02-20
Published 2024-02-26
References
Khoshbaten M, Madad L, Baladast M, Mohammadi M, Aliasgarzadeh A. Gastrointestinal signs and symptoms among persons with diabetes mellitus. Gastroenterology and hepatology from bed to bench. 2011;4(4):219.
Lozeron P, Nahum L, Lacroix C, Ropert A, Guglielmi JM, Said G. Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. Journal of neurology. 2002;249:569-575. DOI: https://doi.org/10.1007/s004150200066
Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Archives of internal medicine. 2001;161(16):1989-1996.
Bytzer P, Talley NJ, Leemon M, Young LJ, Jones MP, Horowitz M. Prevalence of gastrointestinal symptoms associated with diabetes mellitus: a population-based survey of 15,000 adults. Arch Intern Med. 2001;161:1989-1996. DOI: https://doi.org/10.1001/archinte.161.16.1989
Wang X, Pitchumoni CS, Chandrarana K, Shah N. Increased prevalence of symptoms of gastroesophageal reflux diseases in type 2 diabetics with neuropathy. World J Gastroenterol. 2008;14(5):709-712. DOI: https://doi.org/10.3748/wjg.14.709
Oh JH, Choi MG, Kang MI, Lee KM, Kim JI, Kim BW, et al. The prevalence of gastrointestinal symptoms in patients with non-insulin dependent diabetes mellitus. The Korean journal of internal medicine. 2009;24(4):309. DOI: https://doi.org/10.3904/kjim.2009.24.4.309
Zhao J, Frokjare BJ, et al. Upper gastrointestinal sensory-motor dysfunction in diabetes mellitus. World J of Gastroenterol. 2006;12(18):2846-2857.Vinik IA, Maser ER et al. Diabetic Autonomic Neuropaty. Diabetes Care. 2003; 26 (5):1553-1574 DOI: https://doi.org/10.3748/wjg.v12.i18.2846
Zawada AE, Moszak M, Skrzypczak D, Grzymisławski M. Gastrointestinal complications in patients with diabetes mellitus. Adv Clin Exp Med. 2018 Apr;27(4):567-572. doi: 10.17219/acem/67961. PMID: 29533548. DOI: https://doi.org/10.17219/acem/67961
Portincasa P, Bonfrate L, Wang DQ, Frühbeck G, Garruti G, Di Ciaula A. Novel insights into the pathogenic impact of diabetes on the gastrointestinal tract. Eur J Clin Invest. 2022 Nov;52(11):e13846. doi: 10.1111/eci.13846. Epub 2022 Aug 8. PMID: 35904418. DOI: https://doi.org/10.1111/eci.13846
Bytzer P, Talley NJ, Hammer J, Young LJ, Jones MP, Horowitz M. GI symptoms in diabetes mellitus are associated with both poor glycemic control and diabetic complications. Am J Gastroenterol 2002; 97: 604-611 DOI: https://doi.org/10.1111/j.1572-0241.2002.05537.x
Ebert EC. Gastrointestinal complications of diabetes mellitus. Disease-a-Month. 2005;51(12):620-663. DOI: https://doi.org/10.1016/j.disamonth.2005.11.002
Kinekawa F, Kubo F, Matsuda K, Fujita Y, Tomita T, Uchida Y, Nishioka M. Relationship between esophageal dysfunction and neuropathy in diabetic patients. The American journal of gastroenterology. 2001;96(7):2026-2032. DOI: https://doi.org/10.1111/j.1572-0241.2001.03862.x
Armstrong D, Marshall JK, Chiba N, et al; for the Canadian Association of Gastroenterology GERD Consensus Group. Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults. Update 2004. Can J Gastroenterol 2005; 19(1): 15-35 DOI: https://doi.org/10.1155/2005/836030
Talaie R, Forootan M, Donboli K, et al. 24-Hour Ambulatory pH-Metry in Patients with Refractory Heatburn: A Prospective Study. J Gastrointestin Liver Dis. 2009;18 (1): 11-15
Kim GH, Huh KC, Lee YC, et al. Normal Ambulatory 24-Hour Esophageal pH Values in Koreans-A Multicenter Study. J Korean Med Sci. 2008; 23: 954-8 DOI: https://doi.org/10.3346/jkms.2008.23.6.954
Johnson LF, DeMeester TR. Development of the 24-hour intraesophageal pH monitoring composite scoring system. J Clin Gastroenterol. 1986;8(Suppl 1):52-8. DOI: https://doi.org/10.1097/00004836-198606001-00008
Charan M, Matthew G, Katz PO. pH Testing. Atlas of gastrointestinal motility in health and disease . Crowell, Koch, Schuster. 2002: 123-135
Jamieson JR, Stein HJ, DeMeester TR, et al. Ambulatory 24-h esophageal pH monitoring: normal values, optimal thresholds, specificity, sensitivity, and reproducibility. Am J Gastroenterol. 1992; 87:1102-1111
Buzás GM. Functional dyspepsia: the past, the present and the Rome III classification. Orv Hetil. 2007 Aug 19;148(33):1573-9 DOI: https://doi.org/10.1556/oh.2007.28131
Bor S, Mandiracioglu A, Kitapcioglu G, et al. Gastroesophageal reflux disease in a low –income region in Turkey. Am J Gastroenterol 2005;100: 759-65 DOI: https://doi.org/10.1111/j.1572-0241.2005.41065.x
Wong RK, Hanson DG, Waring PJ, Shaw G. ENT manifestations of gastroesophageal reflux. The American journal of gastroenterology. 2000;95(8):S15-S22. DOI: https://doi.org/10.1016/S0002-9270(00)01074-1
Feldeman M, Shiller LR. Disorders of gastrointestinal motility associated with diabetes mellitus. Arch Intern Med. 1983;98:378-84 DOI: https://doi.org/10.7326/0003-4819-98-3-378
Master RF, Pfeifer MA, Dorman JS, et al. Diabetic autonomic neuropathy and cardiovascular risk. Arch Intern Med. 1990;150:1218-22 DOI: https://doi.org/10.1001/archinte.150.6.1218
Pace F, Bollani S, Molteni P, Bianchi Porro G. Natural history of gastro-oesophageal reflux disease without oesophagitis (NERD) - a reappraisal 10 years on. Dig Liver Dis. 2004 Feb; 36(2):111-5. DOI: https://doi.org/10.1016/j.dld.2003.10.012
Nishida T, Tsuji S, Tsujii M, Arimitsu S, Sato T, Haruna Y, et al. Gastroesophageal reflux disease related to diabetes: analysis of 241 cases with type 2 diabetes mellitus. Journal of gastroenterology and hepatology. 2004;19(3):258-265.. DOI: https://doi.org/10.1111/j.1440-1746.2003.03288.x
Camilleri M. Clinical practice. Diabetic gastroparesis N.Engl J Med. 2007; 356(8): 820-829 DOI: https://doi.org/10.1056/NEJMcp062614
Jacobson BC, Somers SC, Fuchs CS, Kelly CP, Camargo CA Jr. Body-mass index and symptoms of gastroesophageal reflux in women. N Engl J Med 2006; 354: 2340-2348 DOI: https://doi.org/10.1056/NEJMoa054391
El-Serag HB, Graham DY, Satia JA, Rabeneck L. Obesity is an independent risk factor for GERD symptoms and erosive esophagitis. Am J Gastroenterol 2005; 100: 1243-1250 DOI: https://doi.org/10.1111/j.1572-0241.2005.41703.x
Yuan S, Larsson SC. Adiposity, diabetes, lifestyle factors and risk of gastroesophageal reflux disease: a Mendelian randomization study. Eur J Epidemiol. 2022 Jul;37(7):747-754. doi: 10.1007/s10654-022-00842-z. Epub 2022 Feb 4. PMID: 35119566; PMCID: PMC9329382. DOI: https://doi.org/10.1007/s10654-022-00842-z